Serotonin and Migraine: Biology and Clinical Implications

  title={Serotonin and Migraine: Biology and Clinical Implications},
  author={Edith Hamel and Headache Currents},
  pages={1293 - 1300}
Migraine is the most frequent neurological disorder in the adult population worldwide, affecting up to 12% of the general population and more frequent in women (~25%). It has a high impact on our society due to its disabling nature and, therein, reduced quality of life and increased absenteeism from work. Headache is the primary clinical manifestation and it has been associated with ‘a hereditary or predisposed sensitivity of neurovascular reactions to certain stimuli or to cyclic changes in… 

Figures from this paper

The Biology of the Glutamatergic System and Potential Role in Migraine

Recent findings that support a role for altered Glutamatergic neurotransmission from biochemical and genetic studies in the manifestation of migraine are outlined and the implications of this on migraine treatment are outlined.

Platelets and migraine.

Studies on the Pathophysiology and Genetic Basis of Migraine

The genetic component of migraine has been teased apart using linkage studies and both candidate gene and genome-wide association studies, in family and case-control cohorts.

Serotonin and migraine: a reconsideration of the central theory

The alteration of peripheral and central 5-HT parameters in migraine patients is discussed and the interpretation of the effects of some serotonergic drugs and recent neuroimaging studies give major evidence for this cascade of events.

Molecular factors in migraine

The understanding of the molecular mechanisms of migraine, including genotype-phenotype correlations, may contribute to finding markers important for the diagnosis and treatment of this disease.

Serotonergic mechanisms in the migraine brain – a systematic review

Most likely, migraine patients have a low cerebral serotonin level between attacks, which elevates during a migraine attack, and novel methods of investigating the serotonergic system in the migraine brain are warranted.

Pathophysiological Bases of Comorbidity in Migraine

The treatment of migraine should always involves a multidisciplinary approach, aimed at identifying and, if necessary, eliminating possible risk and comorbidity factors.

Does the Neurobiology of Migraine Make Migraine Patients “Difficult”?

These results argue in favor of a shared etiology of both migraine and affective disorders, and underlines that psychiatric comorbidity alone is not sufficient to explain a disease-specific personality type.

ASICs as therapeutic targets for migraine

  • G. Dussor
  • Biology, Psychology
  • 2015

Serotonin in Neurological Diseases

It seems that 5-HT and its metabolites may be used as a diagnostic and prognostic marker for neurological diseases or a target for more efficient therapy in neurology in the future.



The biology of serotonin receptors: focus on migraine pathophysiology and treatment.

  • E. Hamel
  • Biology, Medicine
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  • 1999
The recent availability of subtype selective 5-HT1D and 5- HT1F receptor agonists should allow a further test of the neural/vascular hypothesis and could possibly lead to antimigraine drugs with a safer cardiovascular profile.

On Serotonin and Migraine: A Clinical and Pharmacological Review

Stimulation of vascular 5-HT1 receptors, probably located in the vessel wall within the dural vascular bed, may alleviate the headache and associated symptoms, but does not interact with earlier mechanisms within the pathophysiological cascade.

5-Hydroxytryptamine and the pathophysiology of migraine

There seems convincing evidence that central release of 5-HT by various drug mechanisms causes migraine-like headache in migraineurs, but it remains to be seen whether these drugs mimic the pathological event initiating the spontaneous migraine attack.

Increased brain serotonin synthesis in migraine.

The findings indicating increased brain serotonin synthesis capacity in migraine patients are consistent with previous reports of systemic alteration of serotonin metabolism in patients without aura and suggest that the mechanism of action of beta-adrenergic antagonists for migraine prophylaxis may involve regulation of serotonin synthesis.

Increased serotonin transporter availability in the brainstem of migraineurs

This study demonstrates for the first time a significant increase of brainstem SERT-availability in migraineurs, suggesting a dysregulation of the brainstem serotonergic system.

Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine

It is found that there is no association between the functional MAO-A-LPR and susceptibility to migraine, and effectiveness of the potent serotonergic antimigraine agents, triptans, was clinically not affected by the MAO/LPR in patients.


The results support that the genetic susceptibility of migraine may be associated with a locus at or near the 5-HT transporter gene.

Monoamine oxidases A and B gene polymorphisms in migraine patients

Migraine and psychopathology. Results of the Zurich cohort study of young adults.

The data suggest that migraine with anxiety and depression may constitute a distinct syndrome comprising anxiety, often manifested in early childhood, followed by the occurrence of migraine headaches, and then by discrete episodes of depressive disorder in adulthood.

Activation of Meningeal 5‐HT2B Receptors: An Early Step in the Generation of Migraine Headache?

The hypothesis that 5‐HT2B receptors located on endothelial cells of meningeal blood vessels trigger migraine headache through the formation of nitric oxide is supported.